Pulmonary Arterial Hypertension Market Demonstrates Strong Momentum Driven by Advancing Therapies and Rising Disease Awareness Pulmonary Arterial Hypertension (PAH) market is estimated to be valued at several billion US dollars in the early 2020s and is projected to register steady growth over the forecast period, supported by increasing prevalence of rare cardiovascular...